Check 35,000+ stocks against 26 valuation models and 37 quality factors

Kato Hong Kong Holdings Ltd (2189) fair value: what the stock is really worth

As of Sep 30, 2026: fair value of Kato Hong Kong Holdings Ltd HK$0.75, price HK$0.47, upside +61.3%, quality 66 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? Yes
Good quality? Yes
Add to watchlist

Healthcare · HK · ISIN KYG5216P1063

KH Thin data Sep 27, 2026

Kato Hong Kong Holdings Ltd

2189 · HK

Clearly undervaluedStrong Fair Value upside, but quality is only moderate.

✓Fair value HK$0.7500 · Strongly undervalued (+61.3%)

✓Quality 66/100

!Weak Growth (revenue 5y +6.6 %/yr)

!Thin margins · 9.7% net margin (TTM)

✓Low debt · generates free cash flow

✓6.5% dividend yield · Sustainable

✓Ranks above peers (12/14)

!Narrow moat 42/100

!Evidence only low, so the estimate is less certain

26 models, one by oneBear HK$0.5600 to bull HK$0.9400 Growth analysisrevenue history, year by year Quality 66/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Kato Hong Kong Holdings Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.

How to read this chart

60‑month range HK$0.3817 – HK$0.5388 · fair‑value band HK$0.5600 – HK$0.9400 · the HK$0.4650 price screens below the HK$0.7500 fair value. Dashed = 300-day average. As of Sep 27, 2026.

Follow Kato Hong Kong Holdings in your weekly email

Every Wednesday you see whether Kato Hong Kong Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Kato (Hong Kong) Holdings Limited, an investment holding company, operates as a residential care home for the elderly in Hong Kong. The company operates in two segments, Elderly Care Services and Investment Properties Holding. It provides residential care services for the elderly, including provision of accommodation, professional nursing and care-taking, nutritional management, medical, physiotherapy and occupational therapy, physiotherapy and occupational therapy, psychological and social care, and individual care and recreational services. The company also sells healthcare and medical goods; and offers add-on healthcare services to its residents. In addition, it is involved in the operation of home care support services; provision of medical and laboratory services; and property rental and management activities. The company operates care and attention homes for the elderly under the Fai To, Kato, Happy Luck Home, Tsuen Wan Centre, Pine Villa, Hing Ten Elderly Centre, and Ka Shui Garden brand names. It serves the social welfare department and individual customers. The company was founded in 1991 and is based in Tuen Mun, Hong Kong. Kato (Hong Kong) Holdings Limited is a subsidiary of Sheung Fung Limited.

Stock analysis

Kato Hong Kong Holdings Ltd (2189) currently trades at HK$0.4650, while our model-based Fair Value estimate is HK$0.7500, implying the stock looks roughly 38.0% undervalued today.

Valuation

Bull case: the DCF Models group reads highest at a median of HK$0.9900 per share, and 18 of the 26 models we run sit above the HK$0.4650 price.

Bear case: the Dividend Discount group reads lowest at HK$0.2200, and 8 of the 26 models stay below the price. Evidence for this calculation is low.

Scenario range: HK$0.5600 (bear) to HK$0.9400 (bull), the price of HK$0.4650 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 66/100 (solid quality), in the Healthcare sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Kato Hong Kong Holdings Ltd reported revenue of HK$354M in FY2026 versus HK$320M in FY2022, a compound +2.5%/yr. Reported net income was HK$34.2M in FY2026, compounding −23.3%/yr from FY2022.

Key figures

Market cap HK$465M (≈ $59.3M) · P/E ratio 15.5 · P/S ratio 1.50 · EPS (TTM) HK$0.0300 · Dividend yield 6.5% · Net margin 9.7% · Return on equity 7.5% · Return on assets (EBIT) 13.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).

What moves the price

The share trades about 6% below its 52-week high and 16% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 21% fair-value upside, at 61%, 2189 screens cheaper than that median.

Fair Value models

Bear HK$0.5600 Fair Value HK$0.7500 Bull HK$0.9400

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

FCF DCF HK$0.7900 HK$1.27 HK$1.94 79

Growth DCF HK$0.7800 HK$1.20 HK$1.75 78

Residual Income HK$0.3400 HK$0.3500 HK$0.3800 76

All 26 models by family

DCF Models

FCF DCF HK$0.7900 HK$1.27 HK$1.94 79

Owner Earnings HK$0.6000 HK$0.9900 HK$1.52 75

5Y Revenue Exit HK$0.5900 HK$0.9800 HK$1.49 71

5Y EBITDA Exit HK$0.9300 HK$1.66 HK$2.56 74

5Y P/E Exit HK$0.5600 HK$0.9200 HK$1.31 70

10Y Revenue Exit HK$0.6500 HK$1.01 HK$1.51 66

10Y EBITDA Exit HK$0.8500 HK$1.43 HK$2.26 67

10Y P/E Exit HK$0.6500 HK$0.9700 HK$1.39 64

Earnings-Based

Graham-Dodd HK$0.2300 HK$0.9900 HK$1.35 64

Lynch FV HK$0.2500 HK$0.3600 HK$0.4700 61

PEG = 1.0 HK$0.2500 HK$0.3600 HK$0.4700 57

EPV HK$0.2600 HK$0.3000 HK$0.3400 74

Dividend Discount

Gordon GGM HK$0.1400 HK$0.2300 HK$0.3000 68

DDM Multi-Stage HK$0.1400 HK$0.2200 HK$0.2500 67

Multiples

P/E Multiple HK$0.5600 HK$0.7500 HK$0.9400 63

P/S Multiple HK$0.4400 HK$0.5800 HK$0.7300 58

P/B Multiple HK$0.4400 HK$0.5800 HK$0.7300 55

EV/EBIT HK$0.7000 HK$0.9700 HK$1.25 66

EV/EBITDA HK$1.16 HK$1.58 HK$2.00 67

EV/Revenue HK$0.4700 HK$0.7200 HK$0.9700 53

Asset-Based

NCAV (Graham) HK$0.2300 HK$0.3000 HK$0.4500 54

Growth DCF

Growth DCF HK$0.7800 HK$1.20 HK$1.75 78

Rev-Margin DCF HK$0.5900 HK$0.9800 HK$1.48 72

Economic Profit

Residual Income HK$0.3400 HK$0.3500 HK$0.3800 76

ROIC Compounder HK$0.2600 HK$0.3000 HK$0.3400 72

Growth Earnings

Growth-Adj P/E HK$0.4400 HK$0.6200 HK$0.8100 67

Open the full fair value analysis →

Notify me when 2189 reaches fair value

Put 2189 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 66/100

Of which business quality 66 · Market factors (momentum, volatility) 52

Profitability 35

Margins and returns on capital today

Quality Growth 58

Are margins and returns improving?

Cashflow 95

Earnings quality: real cash, not paper profit

Fin. Strength 58

Balance sheet, leverage, solvency risk

Investment 76

Disciplined investing over empire-building

Low Volatility 50

Calm price path (market factor)

Momentum 51

Price trend over the last 3–12 months (market factor)

52W Momentum 57

Distance to the 52-week high (market factor)

Net Issuance 82

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100

Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Revenue growth 1 year

+11.6%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

−4.7%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+6.6%

Start year 2021 (pandemic). Over 10 years: +9.5% a year

Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+9.5%

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

’26

What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.

−9.1%

Earnings growth per share plus dividend.

Earnings per share, growth per year−15.6%

Dividend (yield on the price)6.5%

Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−15.6% vs 0.6%, slowing

Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.38% → 18%

Start year 2021 (pandemic)

Growth Forecast

Little optimism in the price

The price assumes less growth than the company has delivered so far.

What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).

−6.9%

Yearly growth needed for the next five years to justify today's price.

What forecasts expect

n/a

No analyst forecast available.

After inflation (Hong Kong: IMF forecast 2.1% a year to 2030, 1.8% from 2016 to 2025) that is about −8.8% a year for the price.

Watch 2189, get fair value alerts →

Compare Kato Hong Kong Holdings Ltd with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 249 stocks

Beats the industry median on 12/14 measures

Overall it ranks above its industry peers.

Valuation

Quality Score 66 · Top 25%

Fair Value upside +61.3% · Top 25%

Profitability

Return on equity (TTM) 7.5% · Below median

Return on assets 5.0% · Above median

Net margin (TTM) 9.7% · Above median

Operating margin (TTM) 11.2% · Above median

Growth and dividend

Revenue growth 6.1% · Above median

Dividend yield (TTM) 6.5% · Top 25%

Balance sheet

Debt / equity 0.40× · Above median

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/E (TTM) 15.5× · Cheaper than median

P/B 1.02× · Cheaper than median

P/S (TTM) 1.31× · Cheaper than median

P/FCF 5.1× · Cheapest 25%

EV/EBITDA 7.4× · Cheaper than median

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)100 · sector 33

FUTURE (revenue growth)31 · sector 26

PAST (return on equity)30 · sector 30

HEALTH (low debt)80 · sector 89

DIVIDEND (yield)100 · sector 41

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
HCA Healthcare, Inc HCA	$431.63	$597.97	+39%
Fresenius SE FRE	€46.15	€34.49	−25%
Dr. Sulaiman Al Habib Medical Services Group 4013	225.00 SAR	109.45 SAR	−51%
Tenet Healthcare Corporation THC	$257.93	$274.35	+6%
Apollo Hospitals Enterprise Limited APOLLOHOSP	₹8,889	₹2,908	−67%
Encompass Health Corporation EHC	$123.47	$94.47	−23%
Fresenius Medical Care AG FMS	$22.27	$45.84	+106%
DaVita Inc DVA	$178.07	$215.81	+21%
Aier Eye Hospital Group 300015	¥7.91	¥10.86	+37%
Universal Health Services, Inc UHS	$175.73	$444.19	+153%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Kato Hong Kong Holdings Ltd · Fair Value
HK$0.7500 +38%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/2189" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Kato Hong Kong Holdings Ltd · Fair Value</span><br><b style="font-size:20px">HK$0.7500</b> <span style="color:var(--fvc-g-mitte);font-weight:700;font-size:14px">+38%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Kato Hong Kong Holdings Ltd Fair Value". https://www.fairvalue-calculator.com/stock/2189

Frequently asked questions

Is Kato Hong Kong Holdings Ltd (2189) overvalued or undervalued?

As of Sep 27, 2026, our model estimates a fair value of HK$0.7500 versus a price of HK$0.4650, about +61% upside (undervalued).

What is the fair value of 2189?

Our model-based fair value for Kato Hong Kong Holdings Ltd is HK$0.7500 (as of Sep 27, 2026), built from audited fundamentals. The current price: HK$0.4650.

What is the quality score of 2189?

Kato Hong Kong Holdings Ltd has a Quality Score of 66/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Kato Hong Kong Holdings Ltd (2189)?

Our model-based price target is the fair value of HK$0.7500 (as of Sep 27, 2026) from 26 valuation models. Cautious scenario HK$0.5600, optimistic scenario HK$0.9400. It is a calculation from audited fundamentals, not an analyst target.

What is the Kato Hong Kong Holdings Ltd stock forecast for 2026?

Our models put fair value at HK$0.7500, about +61% upside versus a price of HK$0.4650 (undervalued). Cautious scenario HK$0.5600, optimistic scenario HK$0.9400. The calculation is refreshed regularly with new filings.

What is the revenue of Kato Hong Kong Holdings Ltd (2189)?

Kato Hong Kong Holdings Ltd reported trailing-twelve-month revenue of about HK$354M (latest available figure, as of Sep 27, 2026).

Does Kato Hong Kong Holdings Ltd pay a dividend?

Kato Hong Kong Holdings Ltd currently shows a dividend yield of about 6.45% relative to its recent price (as of Sep 27, 2026).

What growth is priced into Kato Hong Kong Holdings Ltd (2189)?

For today's price to be fair in a discounted-cash-flow model, Kato Hong Kong Holdings Ltd would have to grow free cash flow by -6.9 % per year for five years (discount rate 11.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +6.6 % per year. As of Sep 27, 2026.

What discount rate (WACC) does the fair value of 2189 use?

Our models discount Kato Hong Kong Holdings Ltd at 11.8 %: a base by market capitalisation (micro), damped by beta 0.01, country premium for Hong Kong. The same rate applies in all 26 models.

What is a reverse DCF?

A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Kato Hong Kong Holdings Ltd that is -6.9 % per year a year over ten years, using the same discount rate (11.8 %) and the same formula as our fair value.

How much growth has Kato Hong Kong Holdings Ltd (2189) delivered so far?

Over the past 5 years revenue at Kato Hong Kong Holdings Ltd grew +6.6 % a year. The price currently implies -6.9 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.

How fast is the sector of Kato Hong Kong Holdings Ltd (2189) growing?

The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into Kato Hong Kong Holdings Ltd (-6.9 % per year a year): it shows whether the expectation is within the usual range or beyond it.

What is the free cash flow yield of Kato Hong Kong Holdings Ltd (2189)?

The free-cash-flow yield on the price is 19.70 %: that much free cash flow Kato Hong Kong Holdings Ltd produces per unit of market value. When it exceeds the discount rate of our models (11.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.

What is the intrinsic value of Kato Hong Kong Holdings Ltd (2189)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Kato Hong Kong Holdings Ltd it is HK$0.7500 per share (as of Sep 27, 2026), against a price of HK$0.4650. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).

Is Kato Hong Kong Holdings Ltd stock overvalued or undervalued in 2026?

As of Sep 27, 2026, 2189 trades below its calculated fair value: price HK$0.4650, fair value HK$0.7500, a gap of about +61% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of 2189?

No. The price is what the market pays today (HK$0.4650); the fair value is what the company's own numbers justify (HK$0.7500). For Kato Hong Kong Holdings Ltd the two are HK$0.2850 per share apart. That gap is exactly why we show both numbers side by side.

How much is Kato Hong Kong Holdings Ltd worth?

The market values Kato Hong Kong Holdings Ltd at about HK$465M (market capitalisation, as of Sep 27, 2026). Per share that is HK$0.4650; our models calculate a fair value of HK$0.7500 per share.

What do the bullish and bearish scenarios say about 2189?

Our models span a range for Kato Hong Kong Holdings Ltd: cautious scenario HK$0.5600, base HK$0.7500, optimistic HK$0.9400 per share (as of Sep 27, 2026, price HK$0.4650). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the P/E ratio of 2189?

Kato Hong Kong Holdings Ltd trades at a price-to-earnings ratio of 15.5 (as of Sep 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of HK$0.7500 is built from several models across several years. Other multiples: P/B 1.0, P/S 1.3, EV/EBITDA 7.4.

How solid is the balance sheet of Kato Hong Kong Holdings Ltd (2189)?

Balance-sheet figures for Kato Hong Kong Holdings Ltd (as of Sep 27, 2026): return on equity 7.5%, debt of 0.40 per unit of equity. They feed the Quality Score of 66/100, which measures business quality independently of the share price.

How far is 2189 from its 52-week high?

Kato Hong Kong Holdings Ltd trades at HK$0.4650, about 6% below its 52-week high of HK$0.4950 and 16% above the low of HK$0.3995 (as of Sep 30, 2026). Distance from the high says nothing about value: that is what the fair value of HK$0.7500 is for.

Which stocks are comparable to Kato Hong Kong Holdings Ltd?

From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, Tenet Healthcare Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Kato Hong Kong Holdings Ltd stock attractive at the current price?

The data as of Sep 27, 2026: price HK$0.4650, calculated fair value HK$0.7500 (+61%), Quality Score 66/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of 2189 calculated?

We run Kato Hong Kong Holdings Ltd through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of HK$0.7500, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 14.7 % above its aggregate fair value. Kato Hong Kong Holdings Ltd currently trades 38 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Kato Hong Kong Holdings Ltd (2189)?

The closing price on Sep 30, 2026 was HK$0.4650. Our model-based fair value is HK$0.7500, about +61% upside (undervalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Kato Hong Kong Holdings Ltd right now?

The price is below even our cautious bear case (HK$0.5600). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (66/100) at a price below fair value, the discount is the argument here, not the business quality.

Where does the earnings growth of Kato Hong Kong Holdings Ltd (2189) come from?

Earnings per share at Kato Hong Kong Holdings Ltd grew +2.6 % a year from 2016 to 2026. Broken into its drivers: revenue per share +9.4 %, EBIT margin +0.3 %, tax rate −0.8 %, residual (interest, one-offs) −5.7 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Kato Hong Kong Holdings Ltd

How large is the market capitalisation of Kato Hong Kong Holdings Ltd (2189)?

The market capitalisation of Kato Hong Kong Holdings Ltd is HK$465M (≈ $59.3M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Kato Hong Kong Holdings Ltd (2189)?

The price-to-sales ratio of Kato Hong Kong Holdings Ltd is 1.50 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Kato Hong Kong Holdings Ltd (2189)?

Earnings per share at Kato Hong Kong Holdings Ltd are HK$0.0300 (price ÷ EPS = P/E 15.5). Earnings per share over the last twelve months: total profit spread across every single share.

What is the dividend yield of Kato Hong Kong Holdings Ltd (2189)?

The dividend yield of Kato Hong Kong Holdings Ltd is 6.5% (payout 100%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.

What is the net margin of Kato Hong Kong Holdings Ltd (2189)?

The net margin of Kato Hong Kong Holdings Ltd is 9.7% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Kato Hong Kong Holdings Ltd (2189)?

The return on equity (ROE) of Kato Hong Kong Holdings Ltd is 7.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Kato Hong Kong Holdings Ltd (2189)?

On an EBIT basis the return on assets of Kato Hong Kong Holdings Ltd is 13.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Kato Hong Kong Holdings Ltd (2189)?

The operating margin of Kato Hong Kong Holdings Ltd is 11.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Kato Hong Kong Holdings Ltd (2189)?

Revenue at Kato Hong Kong Holdings Ltd is growing +6.1% versus a year earlier (3y avg −4.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at Kato Hong Kong Holdings Ltd (2189)?

Earnings per share at Kato Hong Kong Holdings Ltd are growing +5.1% versus a year earlier. How much earnings per share grew versus a year earlier.

How much net debt does Kato Hong Kong Holdings Ltd (2189) carry?

The net debt of Kato Hong Kong Holdings Ltd is HK$202M (fiscal year 2026, ≈ 2.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch Kato Hong Kong Holdings Ltd in the live analysis

One click puts Kato Hong Kong Holdings Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.